Mark Ma

2.7k total citations · 1 hit paper
74 papers, 1.5k citations indexed

About

Mark Ma is a scholar working on Accounting, Immunology and Molecular Biology. According to data from OpenAlex, Mark Ma has authored 74 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Accounting, 24 papers in Immunology and 20 papers in Molecular Biology. Recurrent topics in Mark Ma's work include Biosimilars and Bioanalytical Methods (23 papers), Auditing, Earnings Management, Governance (16 papers) and Corporate Finance and Governance (13 papers). Mark Ma is often cited by papers focused on Biosimilars and Bioanalytical Methods (23 papers), Auditing, Earnings Management, Governance (16 papers) and Corporate Finance and Governance (13 papers). Mark Ma collaborates with scholars based in United States, Slovenia and Canada. Mark Ma's co-authors include Wayne B. Thomas, Ole‐Kristian Hope, Guanmin Liao, Mark T. Bradshaw, Theingi M. Thway, Perry F. Wilson, Terry Shevlin, Vibha Jawa, Qin Li and Binodh DeSilva and has published in prestigious journals such as Biochemistry, Journal of International Business Studies and Journal of Hepatology.

In The Last Decade

Mark Ma

70 papers receiving 1.4k citations

Hit Papers

Agency costs and tax planning when the government is a ma... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Agency costs and tax planning when the government is a major Shareholder
    2018 257 citations Mark Ma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Ma United States 19 719 512 288 234 163 74 1.5k
George Georgiou Australia 21 213 0.3× 178 0.3× 359 1.2× 91 0.4× 118 0.7× 67 1.3k
Fei Leng China 18 115 0.2× 29 0.1× 420 1.5× 82 0.4× 40 0.2× 61 1.4k
Woo‐Jong Lee South Korea 19 608 0.8× 168 0.3× 217 0.8× 106 0.5× 27 0.2× 107 1.4k
Shasha Liu China 20 68 0.1× 119 0.2× 496 1.7× 467 2.0× 16 0.1× 89 1.8k
Joanne Li United States 18 376 0.5× 81 0.2× 154 0.5× 151 0.6× 95 0.6× 68 1.2k
Meng Zhao China 16 118 0.2× 56 0.1× 44 0.2× 21 0.1× 11 0.1× 82 957
Thomas Ho United States 17 640 0.9× 648 1.3× 21 0.1× 10 0.0× 123 0.8× 53 1.9k
Liu Wang China 17 257 0.4× 52 0.1× 118 0.4× 14 0.1× 8 0.0× 85 1.2k

Countries citing papers authored by Mark Ma

Since Specialization
Citations

This map shows the geographic impact of Mark Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ma more than expected).

Fields of papers citing papers by Mark Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ma. The network helps show where Mark Ma may publish in the future.

Co-authorship network of co-authors of Mark Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ma. A scholar is included among the top collaborators of Mark Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ma. Mark Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Mark, et al.. (2024). Seeking justice: Inequitable management compensation and employee whistleblowing. Accounting Organizations and Society. 113. 101576–101576.
2.
Ma, Mark, et al.. (2024). Return-to-Office Mandates. Academy of Management Proceedings. 2024(1). 5 indexed citations
3.
Ma, Mark, et al.. (2024). Return-to-Office Mandates. SSRN Electronic Journal. 4 indexed citations
4.
Billett, Matthew T., Mark Ma, & Xiaoyun Yu. (2024). Torpedo Your Competition: Strategic Reporting and Peer Firm IPO. The Accounting Review. 99(6). 51–73. 2 indexed citations
5.
6.
Ma, Mark, et al.. (2023). Tax Avoidance and Firm Value: Does Qualitative Disclosure in the Tax Footnote Matter?. SSRN Electronic Journal. 2 indexed citations
7.
Lourie, Ben, et al.. (2023). Operating Lease Recognition and Credit Assessment by Banks. SSRN Electronic Journal. 3 indexed citations
8.
Ma, Mark & Wayne B. Thomas. (2021). Economic Consequences of Operating Lease Recognition. SSRN Electronic Journal. 9 indexed citations
9.
Wang, Yiqi, Gen Li, Mark Ma, et al.. (2018). GT-WGS: an efficient and economic tool for large-scale WGS analyses based on the AWS cloud service. BMC Genomics. 19(S1). 959–959. 11 indexed citations
10.
Kathman, Steven J., Theingi M. Thway, Lei Zhou, et al.. (2016). Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins. The AAPS Journal. 18(2). 424–431. 9 indexed citations
11.
12.
13.
Thway, Theingi M., et al.. (2013). Impact of Anti-Drug Antibodies in Preclinical Pharmacokinetic Assessment. The AAPS Journal. 15(3). 856–863. 39 indexed citations
14.
Lee, Ed, Michael Eschenberg, Kinnari Pandya, et al.. (2012). Specific Method Validation and Sample Analysis Approaches for Biocomparability Studies of Denosumab Addressing Method and Manufacture Site Changes. The AAPS Journal. 15(1). 70–77. 1 indexed citations
15.
Wang, Jin, Daniel K. Burns, & Mark Ma. (2012). A Systematic Approach to Investigate The Impact of Nonclinical Blood Processing Deviations on Large-Molecule Drug Bioanalysis. Bioanalysis. 4(4). 359–365. 2 indexed citations
16.
17.
Thway, Theingi M., et al.. (2011). Assessment of Incurred Sample Reanalysis for Macromolecules to Evaluate Bioanalytical Method Robustness: Effects from Imprecision. The AAPS Journal. 13(2). 291–298. 8 indexed citations
18.
Thway, Theingi M., et al.. (2011). Model-based strategy for bioanalytical method comparison: Measurement of a soluble ligand as a biomarker. Journal of Pharmaceutical and Biomedical Analysis. 58. 65–70. 3 indexed citations
19.
Kaplan‐Lefko, Paula, Jonathan D. Graves, Stephen J. Zoog, et al.. (2010). Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types. Cancer Biology & Therapy. 9(8). 618–631. 100 indexed citations
20.
Ray, Chad, Lei Zhou, Jennifer Tsoi, et al.. (2010). A strategy for improving comparability across sites for ligand binding assays measuring therapeutic proteins. Journal of Pharmaceutical and Biomedical Analysis. 53(3). 729–734. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Georgiou Breakdown of academic impact, for papers by Fei Leng Breakdown of academic impact, for papers by Woo‐Jong Lee Breakdown of academic impact, for papers by Shasha Liu Breakdown of academic impact, for papers by Joanne Li Breakdown of academic impact, for papers by Meng Zhao Breakdown of academic impact, for papers by Thomas Ho Breakdown of academic impact, for papers by Liu Wang
Rankless by CCL
2026